.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Cerilliant
Merck
US Army
Citi
Mallinckrodt
Farmers Insurance
Teva
Baxter
McKesson

Generated: December 15, 2017

DrugPatentWatch Database Preview

Deferoxamine mesylate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for deferoxamine mesylate and what is the scope of deferoxamine mesylate patent protection?

Deferoxamine mesylate
is the generic ingredient in two branded drugs marketed by Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, Watson Labs, West-ward Pharms Int, and Novartis, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for deferoxamine mesylate. Four suppliers are listed for this compound.

Pharmacology for deferoxamine mesylate

Drug ClassIron Chelator
Mechanism of ActionIron Chelating Activity

Medical Subject Heading (MeSH) Categories for deferoxamine mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
NovartisDESFERALdeferoxamine mesylateINJECTABLE;INJECTION016267-002May 25, 2000APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsDEFEROXAMINE MESYLATEdeferoxamine mesylateINJECTABLE;INJECTION076806-001Mar 31, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi UsaDEFEROXAMINE MESYLATEdeferoxamine mesylateINJECTABLE;INJECTION078718-002Sep 15, 2009APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
West-ward Pharms IntDEFEROXAMINE MESYLATEdeferoxamine mesylateINJECTABLE;INJECTION078086-001May 30, 2007APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsDEFEROXAMINE MESYLATEdeferoxamine mesylateINJECTABLE;INJECTION076806-002Mar 31, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Gland Pharma LtdDEFEROXAMINE MESYLATEdeferoxamine mesylateINJECTABLE;INJECTION207384-002Sep 29, 2017APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
HospiraDEFEROXAMINE MESYLATEdeferoxamine mesylateINJECTABLE;INJECTION076019-002Mar 17, 2004APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
HospiraDEFEROXAMINE MESYLATEdeferoxamine mesylateINJECTABLE;INJECTION076019-001Mar 17, 2004APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
West-ward Pharms IntDEFEROXAMINE MESYLATEdeferoxamine mesylateINJECTABLE;INJECTION078086-002May 30, 2007APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
NovartisDESFERALdeferoxamine mesylateINJECTABLE;INJECTION016267-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: deferoxamine mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
NovartisDESFERALdeferoxamine mesylateINJECTABLE;INJECTION016267-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Mallinckrodt
US Department of Justice
Harvard Business School
Colorcon
McKinsey
Citi
Chinese Patent Office
Accenture
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot